• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Top 5 AJMC® Articles of October 2018

Article

Here are the top 5 articles for the month of October.

Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of October.

Number 5: A study assessing adherence to National Comprehensive Cancer Network guidelines in the neoadjuvant treatment of breast cancer concluded that adherence to the guidelines leads to improved outcomes.

Number 4: A phase 3 trial has found that some patients with hard-to-treat leukemia and lymphoma showed significant improvement and longer progression-free survival with duvelisib

Number 3: Drs James P Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Physiology or Medicine for their research showing the potential of immune checkpoint inhibitors in cancer.

Number 2: During a session at the National Association of ACOs Fall 2018 conference, panelists discussed how accountable care organizations can design and implement new strategies that deliver high-quality, low-cost care for patients with complex, chronic conditions.

Number 1: A new law signed by California Governor Jerry Brown will put new requirements on pharmacy benefit managers in the state, including barring so-called gag clauses that prevented pharmacists from telling consumers when they would save money by paying cash for a prescription instead of getting it through insurance.

To read all of these articles and more, visit AJMC.com

Related Videos
Video 12 - "Harnessing Indication-Specific Data on Biosimilars"
Video 11 - "An Overview of Biosimilar Extrapolation During FDA Approval"
Video 3 - "Overview of BCG-Unresponsive Bladder Cancer Treatments Landscape"
Video 2 - "Bladder Cancer with FGFR Alterations: THOR-2 Cohort 1 Study at ESMO 2023"
Video 1 - "Biomarkers and Molecular/ Genomic Testing in Genitourinary Cancers"
Related Content
© 2023 MJH Life Sciences
AJMC®
All rights reserved.